4559 — Zeria Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapSuper Stock

Annual cashflow statement for Zeria Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3,920	3,923	5,722	7,273	9,508
Depreciation
Amortisation
Non-Cash Items	95.6	-65.7	439	169	-1,702
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-665	-1,399	-2,481	-433	-3,178
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	7,295	6,894	9,080	13,157	12,184
Capital Expenditures	-1,273	-16,133	-1,421	-2,658	-3,899
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	868	-1,328	-1,472	83.2	-53.6
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-405	-17,461	-2,893	-2,575	-3,952
Financing Cash Flow Items	-2.25	-3.23	-3.52	-3.93	-1.49
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5,878	11,185	-4,841	-7,415	-8,124
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	960	789	1,910	4,515	2,510